Citation: | QIU Jiagao, GU Xuewen, WANG Cuimei. Clinicopathological study of 7 cases with mixed neuroendocrine-non-neuroendocrine neoplasms[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 43-46. DOI: 10.7619/jcmp.20210764 |
[1] |
FRIZZIERO M, WANG X, CHAKRABARTY B, et al. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres[J]. World J Gastroenterol, 2019, 25(39): 5991-6005. doi: 10.3748/wjg.v25.i39.5991
|
[2] |
MENDOZA-MORENO F, DÌEZ-GAGO M R, MÌNGUEZ-GARCÌA J, et al. Mixed adenoneuroendocrine carcinoma of the esophagus: a case report and review of the literature[J]. Niger J Surg, 2018, 24(2): 131-134. doi: 10.4103/njs.NJS_43_17
|
[3] |
YAMAMOTO M, OZAWA S, KOYANAGI K, et al. Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report[J]. Surg Case Rep, 2018, 4(1): 56. doi: 10.1186/s40792-018-0464-x
|
[4] |
KAWAZOE T, SAEKI H, EDAHIRO K, et al. A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett's esophagus: literature and review[J]. Surg Case Rep, 2018, 4(1): 45. doi: 10.1186/s40792-018-0454-z
|
[5] |
DULSKAS A, PILVELIS A. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): a single center case series[J]. Eur J Surg Oncol, 2020, 46(1): 105-107. doi: 10.1016/j.ejso.2019.08.002
|
[6] |
中华医学会病理学分会消化疾病学组, 2020年中国胃肠胰神经内分泌肿瘤病理诊断共识专家组. 中国胃肠胰神经内分泌肿瘤病理诊断共识(2020版)[J]. 中华病理学杂志, 2021, 50(1): 14-20.
|
[7] |
WHO Classification of Tumours Editorial Board. WHO classificaion of tumours of digestive system[M]. Lyon: IARC Press, 2019: 211-220.
|
[8] |
SORBYE H, WELIN S, LANGER S W, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study[J]. Ann Oncol, 2013, 24(1): 152-160. doi: 10.1093/annonc/mds276
|
[9] |
TANG L H, UNTCH B R, REIDY D L, et al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas[J]. Clin Cancer Res, 2016, 22(4): 1011-1017. doi: 10.1158/1078-0432.CCR-15-0548
|
[10] |
SHI H Y, QI C H, MENG L J, et al. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis?A SEER database analysis of 12878 cases[J]. Ther Adv Endocrinol Metab, 2020, 11: 1-10. http://www.researchgate.net/publication/342731234_Do_neuroendocrine_carcinomas_and_mixed_neuroendocrine-non-neuroendocrine_neoplasm_of_the_gastrointestinal_tract_have_the_same_prognosis_A_SEER_database_analysis_of_12878_cases
|
[11] |
LA ROSA S, INZANI F, VANOLI A, et al. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms[J]. Hum Pathol, 2011, 42(10): 1373-1384 doi: 10.1016/j.humpath.2011.01.018
|